Literature DB >> 12201980

Strategies for achieving joint attention when signing to children with Down's syndrome.

John Clibbens1, Gaye G Powell, Ellen Atkinson.   

Abstract

Research indicates that joint attention is an important factor in determining the rate and nature of early vocabulary development in typically developing children. Studies conducted with deaf children acquiring sign language indicate that caregivers adopt special strategies for achieving joint attention with this group: these strategies make allowance for the visual medium in which the language is transmitted. Joint attention is also important for the development of communication in children with Down's syndrome, who also often have restricted attentional capacity. Moreover, there is good evidence that the use of signed input in addition to speech can have significant benefits for these children. This paper reports on a study designed to explore the utility of strategies observed in deaf parents for the achievement of joint attention when signing with children with Down's syndrome. Data are presented from recordings of four children with Down's syndrome and their mothers. The results showed that the mothers were successful in enabling the child to perceive both signed input and contextual referents much of the time, but that the range of strategies used was very limited compared to deaf parents of deaf children. Adopting a wider range of strategies would allow a considerable increase in signed input. Implications for intervention programmes are discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12201980     DOI: 10.1080/13682820210136287

Source DB:  PubMed          Journal:  Int J Lang Commun Disord        ISSN: 1368-2822            Impact factor:   3.020


  1 in total

1.  The impact of object and gesture imitation training on language use in children with autism spectrum disorder.

Authors:  Brooke Ingersoll; Katherine Lalonde
Journal:  J Speech Lang Hear Res       Date:  2010-07-14       Impact factor: 2.297

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.